[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-366837-105":59,"doc-detail-366837-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","novel-4-quinolone-derivative-inflicted-cytotoxicity-via-intrinsic-apoptotic-pathway-activation-on-human-metastatic-triplenegative-breast-cancer-cells","Novel 4-quinolone derivative inflicted cytotoxicity via intrinsic apoptotic pathway activation on human metastatic triplenegative breast cancer cells","","Quinolones show promising anticancer potential, yet current clinical-trial quinolones face efficacy limitations. To address this, the study designed and synthesized novel 4-quinolone-3-carboxamide derivatives (14–67) and screened them by MTT assay for cytotoxicity. Anticancer activity against leukemia and breast cancer cells was evaluated using the Differential Nuclear Staining (DNS) assay. Among tested compounds, 24, 25, 52, and 65 showed strong leukemia activity, while compound 65 produced marked breast cancer growth inhibition with reduced cytotoxicity in non-cancerous cells. Mechanistically, compound 65 triggered apoptosis via membrane depolarization and induced S-phase cell-cycle arrest in MDAMB231/LM2–4 cells, supporting further research.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/novel-4-quinolone-derivative-inflicted-cytotoxicity-via-intrinsic-apoptotic-pathway-activation-on-human-metastatic-triplenegative-breast-cancer-cells/366837/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/novel-4-quinolone-derivative-inflicted-cytotoxicity-via-intrinsic-apoptotic-pathway-activation-on-human-metastatic-triplenegative-breast-cancer-cells/366837.png","ImageObject",300,407,{"name":92,"@type":93},"nayy☆","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-02","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":24},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the goal of designing the novel 4-quinolone derivatives?","Question",{"text":112,"@type":113},"The study aimed to overcome efficacy issues of current clinical-trial quinolones by designing and synthesizing new 4-quinolone-3-carboxamide derivatives with potential anticancer activity.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which assays were used to screen and evaluate anticancer activity?",{"text":117,"@type":113},"Cytotoxicity was screened using the MTT assay, and anticancer activity against leukemia and breast cancer cells was evaluated using the Differential Nuclear Staining (DNS) assay.",{"name":119,"@type":110,"acceptedAnswer":120},"What key biological effects did the most active compound (65) show?",{"text":121,"@type":113},"Compound 65 triggered apoptosis via membrane depolarization and caused cell cycle arrest at the S phase in the MDAMB231/LM2–4 breast cancer cell line.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},366837,1791069248,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":24,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":24,"preview_urls":146},962090893153,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","Author Manuscr ipt Author Manuscr ipt Author Manuscr ipt Author Manuscript  \n\n| | HHS Public Access\u003Cbr>Author manuscript\u003Cbr>Bioorg Chem. Author manuscript; available in PMC 2025 December 04. |\n| --- | --- |\n\nPublished in final edited form as:  \nBioorg Chem. 2025 October ; 165: 109033. doi:10.1016/j.bioorg.2025.109033 .  \nNovel 4-quinolone derivative inflicted cytotoxicity via intrinsic apoptotic pathway activation on human metastatic triplenegative breast cancer cells  \nNursyuhada Azzmana,b, Muhammad Shoaib Ali Gillc, Nurshariza Abdullahd, Denisse A. Gutierreze, Armando Varela-Ramireze, Laura A. Sanchez-Michaele, Jose A. Lopez-Saenze, Mohamad Nurul Azmi Mohamad Taibf, Syed Adnan Ali Shahg,h, Renato J. Aguilerae, Nafees Ahemada,*  \na School of Pharmacy, Monash University Malaysia, Jalan Lagoon Selatan, Bandar Sunway 47500, Selangor Darul Ehsan, Malaysia  \nb Faculty of Pharmacy, Universiti Teknologi MARA, Cawangan Pulau Pinang Kampus Bertam, Kepala Batas 13200, Pulau Pinang, Malaysia  \nc Institute of Pharmaceutical Sciences, University of Veterinary and Animal Sciences, Lahore, Pakistan  \nd Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia, Bandar Sunway 47500, Selangor, Malaysia  \ne Cellular Characterization and Biorepository Core Facility, Border Biomedical Research Center, Department of Biological Sciences, College of Science, The University of Texas at El Paso, 500 West University Avenue, El Paso, TX 79968–0519, United States of America  \nf Natural Products and Synthesis Organic Laboratory (NPSO Lab), School of Chemical Sciences, Universiti Sains Malaysia, Penang 11800, Malaysia  \ng Faculty of Pharmacy, Universiti Teknologi MARA Cawangan Selangor Kampus Puncak Alam, Bandar Puncak Alam 42300, Selangor, Malaysia  \nh Atta-ur-Rahman Institute for Natural Product Discovery (AuRIns), Universiti Teknologi MARACawangan Selangor Kampus Puncak Alam, Bandar Puncak Alam 42300, Selangor, Malaysia  \nThis is an open access article under the CC BY-NC-ND license ([http://creativecommons.org/licenses/by-nc-nd/4.0/](http://creativecommons.org/licenses/by-nc-nd/4.0/)).  \n*[Corresponding author. nafees.ahemad@monash.edu](Corresponding author. nafees.ahemad@monash.edu) (N. Ahemad) .  \nDeclaration of competing interest  \nThe authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.  \nCRediT authorship contribution statement  \nNursyuhada Azzman: Writing – review & editing, Writing – original draft, Visualization, Software, Methodology, Investigation, Formal analysis, Data curation. Muhammad Shoaib Ali Gill: Validation, Methodology, Data curation, Conceptualization. Nurshariza Abdullah: Methodology, Investigation, Formal analysis. Denisse A. Gutierrez: Writing – review & editing, Validation, Software, Methodology, Investigation, Formal analysis. Armando Varela-Ramirez: Writing – review & editing, Visualization, Validation, Software, Investigation, Formal analysis. Laura A. Sanchez-Michael: Investigation. Jose A. Lopez-Saenz: Investigation. Mohamad Nurul Azmi Mohamad Taib: Investigation. Syed Adnan Ali Shah: Investigation. Renato J. Aguilera: Writing – review & editing, Validation, Supervision, Resources, Project administration, Funding acquisition. Nafees Ahemad: Writing – review & editing, Supervision, Resources, Project administration, Methodology, Funding acquisition, Data curation, Conceptualization.  \nAuthor Manuscr ipt Author Manuscr ipt Author Manuscr ipt Author Manuscript  \nAzzman et al. Page 2  \nAbstract  \nQuinolones are a class of compounds that have shown promising potential as anticancer agents.  \nHowever, the current quinolones in clinical trials are currently hampered by their efficacy issues.  \nTherefore, we designed and synthesized novel 4-quinolone-3-carboxamide derivatives 14–67. All the synthesized compounds were initially screened for their cytotoxicity activity using the MTTassay method and ","cbCait6BEgelNENy","https://ap.wps.com/l/cbCait6BEgelNENy","pdf",2305340,45,"English","# Abstract\n# Keywords\n# 1. Introduction","[{\"question\":\"What was the goal of designing the novel 4-quinolone derivatives?\",\"answer\":\"The study aimed to overcome efficacy issues of current clinical-trial quinolones by designing and synthesizing new 4-quinolone-3-carboxamide derivatives with potential anticancer activity.\"},{\"question\":\"Which assays were used to screen and evaluate anticancer activity?\",\"answer\":\"Cytotoxicity was screened using the MTT assay, and anticancer activity against leukemia and breast cancer cells was evaluated using the Differential Nuclear Staining (DNS) assay.\"},{\"question\":\"What key biological effects did the most active compound (65) show?\",\"answer\":\"Compound 65 triggered apoptosis via membrane depolarization and caused cell cycle arrest at the S phase in the MDAMB231/LM2–4 breast cancer cell line.\"}]","Novel 4-quinolone derivative inflicted cytotoxicity via intrinsic apoptotic pathway activation on human metastatic triplenegative breast cancer cells | PDF",1790167825,113,[147,151,155,159,163],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a735b727ae79740465716a790bf708c7.webp",983,1272,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f1b495dc7e7a45f8285271f52a27090f.webp",982,1270,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/29600829df86fadd93027afcc47d1fde.webp",981,1269,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/aed679d201d85d29026f47065f670a2a.webp",980,1268,{"page_no":24,"url":164,"width":165,"height":166},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/52f4820bb130152b5939f26ae83d7f4b.webp",979,1267]